SCHEMBL13071963

SCHEMBL13071963

Cc1cncc(Nc2ccn(COCC[Si](C)(C)C)n2)n1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.32
HTR3A P46098 1/20 0.32
ACP1 P24666 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL400169 0.87 CDK2 (0.38) DGAT1
SCHEMBL401078 0.83 SMN1; SMN2 (0.35) DGAT1
SCHEMBL401945 0.82 MAPT (0.34) DGAT1
SCHEMBL1056138 0.79 PDE10A (0.33)
SCHEMBL15016442 0.75 GRM5 (0.38) DGAT1
SCHEMBL3496820 0.74 DGAT1 (0.35) DGAT1
SCHEMBL3529847 0.74 ABL1 (0.35)
SCHEMBL27076442 0.74 CACNA1G (0.40)
SCHEMBL3527752 0.73
SCHEMBL1052514 0.71 GPR4 (0.32) HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7834018-B2 aurora kinase inhibitors; 2-(thiazol-2-ylamino)pyridine compounds as antitumor agents; 6-((4-(3-chloro-2-fluorobenzoyl)piperazin-1-yl)methyl)-N-thiazol-2-ylpyridin-2-amine for example BANYU PHARMACEUTICAL CO., LTD (JP) 2010-11-16 US disclosed